Averix Bio

If you're attending Cannabis Europa in London this week, I'd love to schedule a time for us to talk about how our 21CFR Parts 210/211 cGMP-compliant cannabinoid ingredients can improve your products. Please contact me via email at [email protected].

Daniel Wadsworth
Business Director, N.A. & EMEAR

P.S. We also now offer an cGMP-compliant API Phytocannabinoid CBD Isolate for your and production.

**pindustry **p

If your company is interested in exploring the human endocannabinoid system and how it processes cannabinoid ingredients for human health, we’d be honored to serve as your research partner and provide you with our cGMP-compliant API Phytocannabinoid CBD isolate.

Note: We successfully completed an independent audit by ProPharma Group in October and are ready to be your trusted partner Tier One supplier. Meet up with us at CPhI Worldwide this week or get in touch at [email protected] or +1 252.220.0887.


**p

Averix Bio is THRILLED to announce that we successfully completed an independent audit for 21 CFR PART 210 and PART 211 cGMP compliance of API Phytocannabinoid CBD isolate in the U.S. as well as for ICH Q7 standards! (API = Active Pharmaceutical Ingredient)

What does this mean? It means pharmaceutical, food and beverage, nutraceutical and cosmetic companies can now secure API Phytocannabinoid CBD isolate for their preclinical research, clinical trials and manufacturing. The compliance audit was conducted by the ProPharma Group, a leading global, independent, single-source provider of regulatory, clinical and compliance services serving pharmaceutical, biotechnology and medical device companies.

This is truly an historic milestone for Averix Bio, the biopharmaceutical sector and the CBD industry. Our goal has been and continues to be known as the ingredient partner of choice for manufacturers in multiple sectors looking for a Tier 1 supplier of trackable, transparent and trustworthy cannabinoid ingredients. Today’s announcement proves that goal can – and will – be achieved.

Congratulations and thank you to our Quality and Compliance team for their expertise, dedication and tireless work that made this possible. BRAVO!

Read our news release here: https://averixbio.com/news-averix-bio-a-botanical-based-cannabinoid-supplier-achieves-cgmp-21-cfr-part-210-and-part-211-and-ich-q7-compliance/

Get in touch with us at averixbio.com. We are ready to partner with you!

**p